Microport Scientific Corp
HKEX:853
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.23
16.16
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Net Margin
Microport Scientific Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
Microport Scientific Corp
HKEX:853
|
20B HKD |
-16%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
218.1B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
205.2B USD |
29%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
141.7B USD |
14%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
135.8B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
126.4B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
49.9B EUR |
9%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
56B USD |
25%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
55.8B USD |
8%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.7B USD |
23%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
37.8B USD |
11%
|
Microport Scientific Corp
Glance View
MicroPort Scientific Corporation, a burgeoning force in the medical devices industry, has carved a niche for itself as an innovative leader headquartered in the bustling city of Shanghai, China. Founded in 1998, the company embarked on its mission to enhance lives by providing cutting-edge medical solutions. Operating in diverse fields such as cardiovascular, orthopedics, endovascular, and neurovascular, MicroPort thrives on its commitment to developing innovative products. The cornerstone of its business model is its robust research and development infrastructure, which fuels a pipeline of new products and drives advancements in medical technology. By leveraging strategic partnerships and acquisitions, MicroPort continually expands its capabilities, tapping into global expertise and elevating its standing in the competitive landscape. The company's revenue model is built upon the sale and distribution of high-performance medical devices across various international markets. Through a vast network of distributors and direct sales teams, MicroPort targets hospitals, clinics, and healthcare providers. Its portfolio includes stents for cardiovascular needs, orthopedic implants, and pacemakers, each designed to address specific therapeutic requirements. The firm's strategic emphasis on innovation, manufacturing prowess, and quality assurance augments its ability to meet rising healthcare demands globally. By focusing on solutions that improve patient outcomes and streamline healthcare delivery, MicroPort not only reinforces its market presence but also captures a significant market share. Thus, through its dual focus on expanding its technological offerings and growing its global footprint, MicroPort sustains its economic engine and continues its trajectory of consistent growth.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Microport Scientific Corp's most recent financial statements, the company has Net Margin of -16.1%.